Ondine Biomedical, Inc. Financial Overview
Ondine Biomedical, Inc.'s market cap is currently £49.89M. The company's EPS TTM is p; its P/E ratio is -2.42; Ondine Biomedical, Inc. is scheduled to report earnings on September 26, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.